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We have been interested in the structure-activity relationships of nitro-polycyclic aromatic hydrocarbons (nitro-PAHs), and have focused on the corre-
lation of structural and electronic features with biological activities, including mutagenicity and tumorigenicity. In our studies, we have emphasized
1-, 2-, 3-, and 6-nitrobenzo[a]pyrenes (nitro-B[a]Ps) and related compounds, all of which are derived from the potent carcinogen benzo[alpyrene.
While 1-, 2-, and 3-nitro-B[a]P are potent mutagens in Salmonella, 6-nitro-B[a]P is a weak mutagen. In vitro metabolism of 1- and 3-nitro-B[a]P has
been found to generate multiple pathways for mutagenic activation. The formation of the corresponding trans-7,8-dihydrodiols and 7,8,9,10-tetrahy-
drotetrols suggests that 1- and 3-nitro-B[a]P trans-7,8-diol-9,10-epoxides are ultimate metabolites of the parent nitro-B[a]Ps. We have isolated a DNA
adduct from the reaction between 3-nitro-B[a]P trans-7,8-diol-anti9,10-epoxide and calf thymus DNA, and identified it as 10-(deoxyguanosin-N2-yl)-
7,8,9-trihydroxy-7,8,9,10-tetrahydro-3-nitro-B[a]P. The same adduct was identified from in vitro metabolism of [3H]3-nitro-B[a]P by rat liver micro-
somes in the presence of calf thymus DNA. A DNA adduct of 3-nitro-B[a]P formed from reaction of N-hydroxy-3-amino-B[a]P, prepared in situ with
calf thymus DNA was also isolated. This adduct was identified as 6-(deoxyguanosin-N2-yl)-3-amino-B[a]P. The same adduct was obtained from incu-
bating DNA with 3-nitro-B[a]P in the presence of the mammalian nitroreductase, xanthine oxidase, and hypoxanthine. These data indicate that a
mammalian nitroreductase can metabolize 3-nitro-B[a]P to an activated derivative that reacts with DNA to give a novel adduct distant from the site of
nitrenium ion formation. Similar DNA adducts were obtained from ring-oxidation and nitroreduction of 1-nitro-B[aIP. Metabolism of 6-nitro-B[a]P
resulted in a different pattern, and DNA adducts have not been detected from chemical or biologic activation. Based on these results, together with
the other findings, we have proposed that orientation of the nitro functional group is a critical structural feature that can affect metabolism, DNA
binding, mutagenicity, and tumorigenicity of nitro-PAHs. Additional data from the derivatives of the nitro-B[a]Ps support this hypothesis. - Environ
Health Perspect 102(Suppl 6):177-184 (1994)
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Introduction
Nitro-polycyclic aromatic hydrocarbons
(nitro-PAHs) are mutagenic and tumori-
genic pollutants that are present in a variety
of environmental samples and in the food
chain (1-10). We have been interested in
the structure-activity relationships ofnitro-
PAHs and have focused on the correlation
between the structural and electronic fea-
tures and the biologic activities, including
mutagenicity and tumorigenicity. Currently
the nitro-PAHs and arylamines studied by
most groups are derived from nontumori-
genic or weakly tumorigenic PAHs such as
pyrene and fluorene. Our interest has been
particularly in the isomeric nitrobenzo[a]-
pyrenes (nitro-B[a]Ps) (4,6,11), which are
derived from the carcinogenic and muta-
genic PAH, benzo[a]pyrene (B[a]P). B[a]P
is the prototype for the study of chemical
carcinogenesis of PAHs. Nitro-B[a]Ps can
This paper was presented at the Fifth International
Conference on Carcinogenic and Mutagenic
N-Substituted Aryl Compounds held 18-21 October
1992 in Wurzburg, Germany.
Address correspondence to Peter Fu, Division of
Biochemical Toxicology (HFT-1 10), National Center
for Toxicological Research, Jefferson, AR 72079-
9502. Telephone (501) 543-7202. Fax (501) 543-7136.
also be considered derivatives of B[a]P.
$tudy ofthe carcinogenesis ofnitro-B[a]Ps
and comparison of the results with that of
B[a]P will provide useful information on
how a nitro group affects the biologic prop-
erties of B[a]P. Thus, the study of struc-
ture-activity relationships of nitro-B[a]Ps
will provide a better understanding not
only of the carcinogenesis of nitro-PAHs
and arylamines, but of the carcinogenesis
ofPAHs as well.
Because nitro-PAHs require metabolic
activation in order to exert their genotoxic
activities (4,6,7), study of structure-activ-
ity relationships of nitro-PAHs has to
include metabolism, DNA adduct forma-
tion, mutagenicity, and tumorigenicity. A
number ofstudies have reported the corre-
lation ofstructural features and mutagenic-
ity in Salmonella. These include: a) the first
half-wave reduction potential (6,12-14),
b) the molecular dimensions and degree of
aromaticity (4,6,15,16), c) the geometric
location and the orientation of the nitro
substituent (4,15,17-20), and d) the num-
ber ofelectrons involved in the first step of
nitroreduction (21,22). We have studied
the metabolism of a series of nitro-PAHs
by rat liver microsomes and determined the
mutagenicity of the nitro-PAH substrates
and their in vitro metabolites in Salmonella.
As a consequence, the metabolic activation
pathways of these compounds that lead to
mutation have been determined, and the
structural and electronic features, which
can be used to interpret and predict the
bacterial mutagenicity of the nitro-PAHs,
also have been determined (4,6,18,19,
23-26). In this article, we report our stud-
ies on the metabolism, mutagenicity, DNA
binding, and tumorigenicity of the iso-
meric nitro-B[a]Ps and related compounds
and discuss the structure-activity relation-
ships ofnitro-PAHs.
Metabolism, Mutagenicity,
and Metabolic Activation
Leading to Mutation
Both 1- and 3-nitro-B[a]P have been
demonstrated to exhibit potent bacterial
and mammalian mutagenicity (8,19,24,25,
27-31). The isomeric mixtures also exhib-
ited greater than additive mutational
responses in Salmonella typhimurium
(32,33). Although 6-nitro-B[a]P is not a
direct-acting mutagen in S. typhimurium
TA98, it is mutagenic in the presence ofS9
activation (8,23,27,28). We have recently
determined the mutagenicity of 2-nitro-
Environmental Health Perspectives 177FUETAL.
B[a]P and found that this isomeric nitro-
B[a]P is a potent mutagen in S. typhimurium
tester strains TA98, TA100, and TA104,
both in the presence and in the absence of
S9 activation enzymes (16).
Incubation of3-nitro-B[a]P under aer-
obic conditions with liver microsomes from
untreated rats and from phenobarbital- and
3-methylcholanthrene-treated rats yielded
3-nitro-B[a]P trans-7,8-dihydrodiol and 3-
nitro-B[a]P trans-9,10-dihydrodiol as pre-
dominant metabolites, and 3-nitro-B[a]P
7,8,9,10-tetrahydrotetrol as a minor
metabolite (24,26). The identification of
3-nitro-B[a]P 7,8,9,10-tetrahydrotetrol as a
metabolite suggests that the vicinal bay-
region trans-7,8-diol anti-9,10-epoxide
was formed during metabolism (24).
Metabolism of 3-nitro-B[a]P under
hypoxic conditions yielded 3-amino-B[a]P
as a predominant metabolite together with
a trace of 3-nitro-B[a]P trans-7,8- and
9,10-dihydrodiol. 3-Nitro-B[a]P and its
trans-dihydrodiol metabolites were potent
direct-acting mutagens in S. typhimurium
TA98, and their mutagenicities were
greatly reduced in TA98NR and
TA98/1,8-DNP6 (24). Unexpectedly, 3-
amino-B[a]P was also a potent direct-acting
mutagen. The lower number of revertants
produced by 3-nitro-B[a]P and its two
trans-dihydrodiol metabolites in TA98NR
suggests the involvement of bacterial
nitroreduction in both the direct and S9-
mediated mutagenicity ofthese three com-
pounds. The lower mutagenicity in
TA98/1,8-DNP6 of 3-nitro-B[a]P trans-
7,8- and 9,10-dihydrodiols in the presence
and absence ofS9 and of3-nitro-B[a]P in
the presence ofS9 suggests that nitroreduc-
tion followed by esterification is necessary
in order to exert the full mutagenicity of
these compounds. However, esterification
is not required for the direct-acting muta-
genicity of 3-nitro-B[a]P (24). Based on
the metabolism and the mutagenicity
results of3-nitro-B[a]P and its metabolites,
multiple metabolic activation pathways
exist, including nitroreduction, ring-oxida-
tion, and ring-oxidation followed by
nitroreduction and esterification. The
metabolic profiles, the mutagenicities of
the metabolites, and the multiple metabolic
activation pathways of 1-nitro-B[a]P are
similar to those of3-nitro-B[a]P (25,34).
In contrast to 1- and 3-nitro-B[a]P, the
metabolism of 6-nitro-B[a]P by rat liver
microsomes under similar conditions gener-
ated 3-hydroxy-6-nitro-B[a]P as the
predominant metabolite and the following
minor metabolites: 1-hydroxy-6-nitro-
B[a]P; 6-nitro-B[a]P 1,9-hydroquinone; 6-
nitro-B[a]P 3,9-hydroquinone; and B[a]P
3,6-quinone (23). The formation of 1-
hydroxy-6-nitro-B[a]P and 6-nitro-B[a]P
1,9-hydroquinone has been shown to be
mediated via the 6-nitro-B[a]P 1,2-epoxide
intermediate (35). Metabolism of B[a]P
under similar conditions produced 3-
hydroxy-B[a]P as the predominant
metabolite, and both B[a]P trans-4,5- and
7,8-dihydrodiols were also formed in con-
siderable quantity. Comparison of the
metabolism patterns between B[a]P and
the 1-, 3-, and 6-nitro-B[a]P indicates that
the nitro group affects the regioselectivity
of the cytochrome P450 isozymes (26).
The major structural difference in these
nitro-B[a]P isomers is that while 1- and 3-
nitro-B[a]P have their nitro group prefer-
entially adopting a parallel (co-planar)
orientation, 6-nitro-B[a]P has its nitro
group in a perpendicular orientation
(14,17). Nitro orientation may be the crit-
ical factor that affects the regioselectivity of
the cytochrome P450 isozymes.
Nitro Orientation and
Mutagenicity in Salmonella
More than 40 structurally related nitro-
PAHs were used to determine the relation-
ships among direct-acting mutagenicity,
orientation of the nitro group, and reduc-
tion potential of the nitro group
(13,14,17). The compounds consisted of
isomeric mononitrated and dinitrated
B[a]P, benzo[e]pyrenes, their derivatives,
and other nitro-PAHs containing from two
to five aromatic rings. A general finding is
that nitro-PAHs with their nitro sub-
stituent oriented perpendicular to the aro-
matic system exhibit either veryweak or no
direct-acting mutagenicity in S.
typhimurium strains TA98 and TA100.
However, ifa nitro-PAH ofthis type has a
relatively low first half-wave reduction
potential, it may be direct-acting (14).
Furthermore, a positive correlation
between the first half-wave reduction
potential and direct-acting mutagenicity is
found only when the compounds are struc-
turally similar (14). Nitro-PAHs with a
perpendicular nitro orientation always have
a higher (absolute value) first half-wave
reduction potential than the isomer(s) with
a parallel orientation.
Nitro Orientation and
Tumorigenicity
Comparison of the tumorigenicity of a
series ofnitro-PAHs and their parent PAHs
in the newborn mouse assay indicates that
addition of a nitro group to a PAH can
drastically alter its tumorigenicity. Based
on the newborn mouse assay studied so far,
we propose that when a nitro group is
introduced to a carcinogenic bay-region
containing PAH and the nitro group ofthe
resulting nitro-PAH preferentially adopts a
perpendicular or nearly perpendicular ori-
entation, the tumorigenicity ofthis nitro-
PAH is weaker than the parent PAH.
Examples include conversion of benz[a]-
anthracene to 7-nitrobenz[a]anthracene,
benzo[a]pyrene to 6-nitrobenzo[a]pyrene,
and dibenz[a,h]anthracene to 7-nitro-
dibenz[a,h]anthracene. As previously
reported by Wislocki et al. (36), the per-
centages of animals bearing liver tumors
induced by 7-nitrobenz[a]anthracene,
benz[a]anthracene, 6-nitrobenzo[a]pyrene,
and benzo[a]pyrene are 28, 79, 28, and
49%, respectively (36). Similarly, the per-
centages ofanimals bearing liver nodules
induced by 7-nitrodibenz[a,h]anthracene
and dibenz[a,h]anthracene are 42 and
100%, respectively (unpublished data).
Because attempts to prepare DNA adducts
by chemical reduction ofthese compounds
followed by reaction with calf thymus
DNA failed, the nitro functional group is
unlikely to be activated by reductive
metabolism (unpublished data). Study of
the oxidative metabolism of these com-
pounds indicates that the formation ofthe
bay-region diolepoxide may not always be
diminished. For example, while metabo-
lism of benz[a]anthracene by mouse liver
microsomes generated benz[a]anthracene
trans-3,4-dihydrodiol in a yield ofless than
4% ofthe total metabolites, metabolism of
7-nitrobenz[a]anthracene under similar
conditions resulted in 7-nitrobenz[a]-
anthracene trans-3,4-dihydrodiol in a
much higher yield (37). These data suggest
that formation of the 7-nitrobenz[a]-
anthracene bay-region diolepoxide should
be no less than that of the benz[a]anthra-
cene bay-region diolepoxide.
DNA Adduct Formation
Covalent bindingofthe activated metabolites
ofchemical carcinogens to cellular DNA is
considered the critical step in the multi-
stage process leading to tumor formation.
We have studied the DNA adduct forma-
tion of a number of nitro-PAHs (38-41).
The studies on 1- and 3-nitro-B[a]P
include a) preparation of DNA adducts by
chemical reduction ofnitro-B[a]Ps to form
the N-hydroxyamino-B[a]Ps in situ fol-
lowed by reaction with calfthymus DNA;
b) use ofthe resulting adducts as standards
to identify the DNA adducts formed from
anaerobic incubation of nitro-B[a]Ps in
vitro; c) preparation of DNA adducts from
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Figure 1. Formation of 6-(deoxyguanosin-N2-yl)-3-aminobenzo[a] pyrene from nitroreduction of3-nitro-B[a]P.
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Figure 2. The proposed SN1 mechanism forthe6-(deoxyguanosin-N2-yl)-3-aminobenzo[a]pyrene formation.
1.81
8 1 2.12
5 4
1.51
10 1 2.31 2
1.68
6 5
1.27 1.57
78 2 1.89
5 10 4
1.96
1.66 1.4 23 2.14 82"
1.92 11 12
10 4 1.84
198
1.98 8 7 6
1.63 1.35 1.66
2.04
1.96 43 2.18
2
6 11.86
7 A10
8 g 1.80
1.80
12 1 2.16
9
10 32.02
a8 5 1.90
7 6 1.90
1.67
2.25
1.50 1.36 1.68 23 1.63
1.81 12 1 2.27 12
1.81 12 1 1 4 ; 1.73
1.73 10 3 1I 4
2.08
2.12
a
7 6 5
4
1.55 1.91 6
5
7
1.55 1.15 1.55
Figure 3. Dewar reactivity numbers for substitution of polycyclic aromatic hydrocarbons.
chemical reaction ofnitro-B[a]P trans-7,8-
diol-anti-9,10-epoxides with calf thymus
DNA; and d) identification of the DNA
adducts derived from nitro-B[a]P diol-
epoxides in vitro. Attempts to prepare DNA
adducts of 6-nitro-B[a]P under similar
conditions failed (e g., to prepare the N-
hydroxy-6-amino-B[a]P in situ followed by
reaction with calfthymus DNA).
DNAAdductsfromNiltroreduction of
3-Nitrobenzo[a]pyrene
N-Hydroxy-3-amino-B[a]P, prepared in
situ from reduction of 3-nitro-B[a]P, was
reacted with calfthymus DNA. After enzy-
matic digestion ofthe DNA, the resulting
modified nucleosides were analyzed by
thermospray HPLC-MS and high resolu-
tion proton NMR spectroscopy, and the
adduct was identified as 6-(deoxyguanosin-
N2-yl)-3-amino-B[a]P (42) (Figure 1). To
avoid steric hindrance, this adduct has its
deoxyguanosinyl moiety perpendicular or
nearly perpendicular to the 3-aminobenzo-
[a]pyrenyl aromatic moiety. The same
adduct was also formed from in vitro incu-
bations of[3H]3-nitro-B[a]P with xanthine
oxidase and rat liver microsomes in the
presence of calf thymus DNA under
hypoxic conditions (42). These results sug-
gest that nitroreduction of3-nitro-B[a]P to
N-hydroxy-3-amino-B[a]P may be a meta-
bolic activation pathway in mammalian sys-
tems. Incubation of S. typhimurium TA98
with [3H]3-nitro-B[a]P was performed,
and the same adduct was detected as the
predominant product (unpublished data).
Thus, because 3-nitro-B[a]P is a potent
direct-acting mutagen (24,28), these results
suggested that 3-nitro-B[a]P is metabolized
by bacterial nitroreductase(s) to N-
hydroxy-3-amino-B[a]P, and the identified
DNA adduct, 6-(deoxyguanosin-N2-yl)-3-
amino-B[a]P, should be the species respon-
sible for the mutation induction by
3-nitro-B[a]P. However, contrary to the
potent mutagenicity, the preliminary
results ofthe newborn mouse tumorigenic-
ity assay indicates that 3-nitro-B[a]P is
weakly tumorigenic; only 5 out of24 mice
developed hepatic nodules (43). These
results suggest that either this adduct is not
formed, or if it is formed, due to its bulky
structure, it is rapidly repaired by the DNA
repair enzymes.
Due to the long-range migration
involved in the formation of 6-
(deoxyguanosin-N2-yl)-3-amino-B[a]P, its
formation likely involves an SNI mecha-
nism that includes a) formation of the
nitrenium ion by removal of the hydroxyl
anion from N-hydroxy-3-amino-B[a]P, b)
Volume 102, Supplement 6, October 1994
DNA
L-
179I1) DNA .
2 Enzymatic ) digestion
0
NN NH ~ ~
N
2
7O 6 5
OH
Figure 4. Formation of the DNA adduct 10-(deoxyguanosin-N2-yl-)-7,8,9-trihydroxy-7,8,9,10-tetrahydro-3-nitro-
benzo[alpyrene (dG-3-nitro-B[a]P-DE) from 3-nitro-B[a]P-trans-7,8-diol-anti-9,10-epoxide.
isomerization of this nitrenium ion to the
energetically more stable carbocation with
the positive charge localized at the C6 posi-
tion, c) attack by this carbocation on calf
thymus DNA, and d) isomerization and
hydride migration to form the adduct
(Figure 2). Ifthe nitrenium ion [NH'] can
be considered as a substituent to the B[a]P
molecule, this long distance migration may
be explicable by perturbation molecular
orbital theory. Based on the simplified
molecular orbital methods, Dewar reactiv-
ity numbers are very useful for prediction
ofsubstitution ofPAHs (44). As shown in
Figure 3, C6 of B[a]P has the lowest
Dewar reactivity number (1.15) not only in
B[a]P, but among the other PAHs shown
in Figure 3 as well. The smaller the Dewar
activity number, the more preferably the
carbocation is formed (localized at that
position), and thus it is more favorable for
substitution or migration of the positive
charge to occur at that position. This may
account for the occurrence of this novel
migration. Herreno-Saenz et al. reported
that reaction of N-hydroxy-3-aminochry-
sene, formed in situ, with calf thymus
DNA generated the N-(deoxyguanosin-C8-
yl)-3-aminochrysene as the predominant
adduct (45). Binding ofcalfthymus DNA
to N-hydroxy-1-aminopyrene formed from
nitroreduction of 1-nitropyrene gave N-
(deoxyguanosin-C8-yl)-1-aminopyrene as
the predominant adduct, and no other
adducts were formed. The lowest Dewar
activity numbers for chrysene and pyrene,
both at the C6 position, are 1.67 and 1.51,
respectively, which are much higher than
the 1.15 at the C6 position of B[a]P
(Figure 3). Thus, the results seem to be
consistent with the prediction by the sim-
plified molecular orbital theory. Deter-
mining whether this electronic feature is the
critical factor in directing the type ofDNA
adduct formed warrants further investiga-
tion.
Formation ofDNAAdduct from
Reaction of3-Nitro-B[a]P-trans-7,8-
diol-andi-9,10-epoxide with Calf
Thymus DNAand Characterization of
theAdduct
In order to prepare the DNA adducts
formed from reactions ofcalfthymus DNA
with the probable ultimate metabolites
formed from enzymatic ring-oxidation of
1-nitro-B[a]P and 3-nitro-B[a]P, respec-
tively, both 1-nitro-B[a]P trans-7,8-diol-
anti-9, 10-epoxide and 3-nitro-B [a]P
trans-7,8-diol-anti-9, 10-epoxide were suc-
cessfully prepared, each by a nine-step total
synthesis (46,47). 3-Nitro-B[a]P trans-7,8-
diol-anti-9,10-epoxide was incubated with
calfthymus DNA. The resulting DNA was
enzymatically digested. By mass and proton
NMR spectral analysis, the nucleoside
adduct was identified as 10-(deoxy-
guanosin-N2-yl-)-7,8,9-trihydroxy-
7,8,9,1 0-tetrahydro-3-nitro-B [a] P
(dG-3-nitro- B[a]P-DE) (Figure 4) (47).
This adduct was optically active, with its
circular dichroism spectrum (data not
shown) similar to that of the dG-B[a]P
7R,8S-diol-9S,jOR-epoxide. Thus, the dG-
3-nitro- B[a]P-DE adduct was preferen-
tially formed by trans-addition of
3-nitro-B[a]P 7R,8S-diol-9S, 1OR-epoxide
to the amino group ofdeoxyguanosine. In
this study, a DNA adduct derived from a
bay-region diolepoxide of a nitro-PAH has
been prepared and characterized for the
first time.
Incubation of [G-3H]3-nitro-B[a]P
with rat liver microsomes in the presence of
calfthymus DNA under aerobic conditions
resulted in the same adduct as a predomi-
nant product (unpublished data). Other
minor DNA adducts were formed, but
were not identified due to the lack of stan-
dards for comparison.
Study of the biologic properties of
B[a]P trans-7,8-diol-anti-9,10-epoxide and
the dG-B[a]P-DE adduct has been central
to the field of carcinogenesis by PAHs.
With the bay-region diolepoxides of 1-
nitro-B[a]P, 3-nitro-B[a]P, and B[a]P now
available from organic synthesis, it is
Table 1. Comparison of the stability and chemical
activities between B[a]P trans-7,8-diol-anti-9,10-epox-
ide and 3-nitro-Bla]P trans-7,8-diol-anti-9,10-epoxide.
S NkQ
Stability Low High
Hydrolysis
THF/H20 Fast Low
Buffer Fast Slow
Buffer/DNA Fast Slow
Toxicity in vivo High Low
DNA binding Low High
important to compare their chemical and
biologic properties. Preliminary data are
shown in Table 1. 3-Nitro-B[a]P trans-7,8-
diol-anti-9,10-epoxide is much more stable
than B[a]P trans-7,8-diol-anti-9, 10-epox-
ide. 3-Nitro-B[a]P trans-7,8-diol-anti-
9,10-epoxide showed no evidence of
decomposition during the HPLC separa-
tion, during NMR spectral measurements,
or after storage at 40C. The effect ofstabi-
lization of this compound by the nitro
group is similar to our previous report that
while anthracene 1,2-epoxide undergoes
rapid nonenzymatic rearrangement (half
life= 1.2 min) to phenols, both 9-nitroan-
thracene 1,2-epoxide and 9-nitroan-
thracene 3,4-epoxide (Figure 5) are much
more stable (48).
Hydrolysis of B[a]P trans-7,8-diol-
anti-9,10-epoxide is much faster than that
of 3-nitro-B[a]P trans-7,8-diol-anti-9,10-
epoxide in tetrahydrofuran, buffer, or the
presence of DNA. 3-Nitro-B[a]P trans-
7,8-diol-anti-9,10-epoxide exhibits higher
binding than B[a]P trans-7,8-diol-anti-
9,10-epoxide does to calf thymus DNA.
B[a]P trans-7,8-diol-anti-9,10-epoxide
exhibits much higher toxicity in newborn
mice. All 58 newborn CD-1 mice receiving
100 nmoles of B[a]P trans-7,8-diol-anti-
9,10-epoxide within 24 hr of birth died
within 30 days after treatment (unpub-
lished data). It has been well established
that prior to covalent binding to DNA,
intercalation of B[a]P trans-7,8-diol-anti-
9,10-epoxide with the bases of the double
helical DNA molecule is required. The
NO2 NO2
0
Figure 5. Structures of 9-nitroanthracene 1,2-epoxide
and 9-nitroanthracene 3,4-epoxide.
Environmental Health Perspectives
FUETAL.
180DNA ADDUCTSAND CARCINOGENICITY OFNITRO-PAHS
NH2
N02 NHOH 1
2
NR 00
7 6 5sL
Ha/g~~~~~~~~~NO Tumuorr
OH O
j N
NO2 NO2
HO' H 0
OH OH
Figure 6. Proposed possible metabolic activation of 1-nitrobenzo[alpyrene leading to tumor initiation.
nitro group is a highly electronegative
functional group and its presence to a PAH
molecule increases the molecular size.
Consequently, addition ofa nitro group to
the B[a]P trans-7,8-diol-anti-9,10-epoxide
molecule may alter the intercalation
efficiency to the double helical DNA.
Thus, it is important to determine, prior to
covalent binding, whether intercalation of
3-nitro-B[a]P trans-7,8-diol-anti-9, 10-
epoxide with the double helical DNA is
critical in covalent binding. It is also
known that DNA catalyzes the hydrolysis
of B[a]P trans-7,8-diol-anti-9,10-epoxide
to the corresponding tetrahydrotetrol and
thus decreases the binding efficiency of
B[a]P trans-7,8-diol-anti-9,10-epoxide to
DNA. Therefore, it is also important to
determine if DNA also catalyzes the
hydrolysis of 3-nitro-B[a]P trans-7,8-diol-
anti-9,10-epoxide to tetrahydrotetrol. All
ofthese areas are now under investigation.
Metabolic Activation of Nitro-
B[aJP Leading to Tumor
Induction
It is important to determine whether or not
tumorigenicity also correlates with bacterial
mutagenicity. Both 1- and 3-nitro-B[a]P
are weak tumorigens when tested in the
newborn mouse bioassay but are potent
mutagens in the Salmonella mutagenicity
assay. Thus, their tumorigenicity does not
correlate with mutagenicity. The proposed
mechanism of bioactivation of 1-nitro-
B[a]P leading to tumor initiation is shown
in Figure 6. The DNA adducts derived
from nitroreduction and from the diol-
epoxide have been prepared. The next step
is to determine whether they are formed in
vivo, and, ifthey are formed, to determine
the quantity and the rate of repair.
Hydrolysis of B[a]P trans-7,8-diol-anti-
9,10-epoxide to the tetrahydrotetrol is a
detoxification pathway. However, this may
not be true for 1-nitro-B[a]P because 1-
nitro-B[a]P tetrahydrotetrol may be acti-
vated by nitroreduction to form the
corresponding N-hydroxyamino species,
which may covalently bind to DNA, and
lead to tumor initiation. Similarly, 1-nitro-
B[a]P trans-7,8-dihydrodiol can also be
activated via nitroreduction. Because 3-
nitro-B[a]P trans-9,10-dihydrodiol is also a
major metabolite, nitroreduction and ring-
oxidation followed by nitroreduction may
be activation pathways for tumor initiation.
Similar activation pathways for 3-nitro-
B[a]P are proposed.
Conclusions
Nitro orientation has been demonstrated to
be an important structural feature in deter-
mining the metabolism pattern, bacterial
mutagenicity, DNA binding, and tumori-
genicity of nitro-PAHs, which exhibit
mutagenicity drastically different from
their parent PAHs. Nitro-PAHs also
exhibit markedly different mutagenicity
among the geometric isomers. In general, a
nitro-PAH with its nitro substituent adopt-
ing a perpendicular orientation exhibits
either very weak or no direct-acting muta-
genicity in S. typhimurium TA98 and
TA100. However, ifa nitro-PAH of this
type has a relatively low first half-wave
reduction potential, it may be direct-acting.
The correlation described above is valid
only when the compounds are structurally
similar.
Covalent binding of DNA to the N-
hydroxy-3-amino-B[a]P formed in situ
results in 6-(deoxyguanosin-N2-yl)-3-
amino-B[a]P which is formed via long-
range migration. To direct the formation
ofthis adduct, it is important to determine
the mechanism of its formation as well as
the determining factor(s) such as electronic
and structural features ofthe molecule and
the active site ofthe double helical DNA.
Nitro-PAHs exhibit tumorigenicity
drastically different from their parent
PAHs. Nitro-PAHs also exhibit markedly
different tumorigenicity among the geo-
metric isomers. When a nitro group is
introduced to a carcinogenic bay-region
containing PAH and the nitro group ofthe
resulting nitro-PAH preferentially adopts a
perpendicular or nearly perpendicular ori-
entation, the tumorigenicity of this nitro-
PAH is weaker than the parent PAH.
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